Options for treating COVID-19 may be increased by modulating type 1 Interferon.

Published Date: 09 Aug 2023

Researchers from Emory University have studied how to modulate the signaling of type 1 Interferon (IFN-I), one of the body's initial defenses, for the first time in nonhuman primates as part of their ongoing efforts to lessen the effects of COVID-19.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot